HyClone’s R&PD group develops serum- and protein-free cell culture media utilizing Metabolic Pathway Design. This development process balances the required nutrient supply against metabolic waste accumulation, determines the effective concentration of medium components, and defines complexed lipids that facilitate stability and nutritional delivery to the cells.

By addressing these requirements, HyClone’s R&PD team develops serum-free, protein-free and chemically-defined media without sacrificing the performance traditionally achieved with serum-containing media. This process also facilitates the design of animal derived component free media.

By applying HyClone’s understanding of the metabolism and characteristics of the major cell platforms employed in modern manufacturing processes, HyClone’s R&PD facility provides services for optimized media development.

HyClone offers a wide variety of options for development collaboration to meet clients’ specific needs for most cell types, culture configurations, and selection/ amplification systems.